Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
about
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.Is there a link between the extracranial venous system and central nervous system pathology?Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis
P2860
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@ast
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@en
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@nl
type
label
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@ast
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@en
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@nl
prefLabel
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@ast
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@en
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@nl
P2093
P2860
P356
P1433
P1476
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.
@en
P2093
Carmela Leone
Emanuele D'Amico
Francesco Patti
Luigi Di Pino
Sabina Cilia
P2860
P2888
P356
10.1186/1471-2377-13-97
P577
2013-07-27T00:00:00Z
P5875
P6179
1022068720